DIANA-microT 2023: including predicted targets of virally encoded miRNAs
Nucleic Acids Research · 05.07.2023 · 51 (W1) · W148-W153
DOI: 10.1093/nar/gkad283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 24.04.2023. Verfasst von Spyros Tastsoglou und 5 weiteren Autor:innen. Beteiligte Einrichtung: DIANA-Lab, Department of Computer Science and Biomedical Informatics, Univ. of Thessaly, Lamia 35131, Greece. Hauptthemen laut MEDLINE: MicroRNAs. Die Arbeit wurde bisher 124-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ELIXIR-GR: The Greek Research Infrastructure for Data Management and Analysis in Life Sciences, Competitiveness, Entrepreneurship and Innovation, European Regional Development Fund.
Abstract (Originalsprache)
DIANA-microT-CDS is a state-of-the-art miRNA target prediction algorithm catering the scientific community since 2009. It is one of the first algorithms to predict miRNA binding sites in both the 3′ Untranslated Region (3′-UTR) and the coding sequence (CDS) of transcripts, with increased performance. Its current version, DIANA-microT 2023 (www.microrna.gr/microt_webserver/), brings forward a significantly updated set of interactions. DIANA-microT-CDS has been executed utilizing annotation information from Ensembl v102, miRBase 22.1 and, for the first time, MirGeneDB 2.1, yielding more than 83 million interactions in human, mouse, rat, chicken, fly and worm species. Additionally, this version delivers predicted interactions of miRNAs encoded from 20 viruses against host transcripts from human, mouse and chicken species. Numerous resources have been interconnected into DIANA-microT, including DIANA-TarBase, plasmiR, HMDD, UCSC, dbSNP, ClinVar, as well as miRNA/gene abundance values for 369 distinct cell-lines/tissues. The server interface has been redesigned allowing users to use smart filtering options, identify abundance patterns of interest, pinpoint known SNPs residing on binding sites and obtain miRNA-disease information. The contents of DIANA-microT webserver are freely accessible and can also be locally downloaded without any login requirements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- DIANA-Lab, Department of Computer Science and Biomedical Informatics, Univ. of Thessaly, Lamia 35131, Greece.
- Hellenic Pasteur Institute, Athens 11521, Greece.
- Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
- Broad Institute of MIT and Harvard, Cambridge, MA, USA.
ORCID-Profile: Artemis G Hatzigeorgiou
Förderung
- ELIXIR-GR: The Greek Research Infrastructure for Data Management and Analysis in Life Sciences
- Competitiveness, Entrepreneurship and Innovation
- European Regional Development Fund
- Hellenic Foundation for Research and Innovation
Zitieren
APA
Tastsoglou, S., Alexiou, A., Karagkouni, D., Skoufos, G., Zacharopoulou, E., & Hatzigeorgiou, A. G. (2023). DIANA-microT 2023: including predicted targets of virally encoded miRNAs. Nucleic Acids Research, 51(W1), W148-W153. https://doi.org/10.1093/nar/gkad283
Vancouver
Tastsoglou S, Alexiou A, Karagkouni D, Skoufos G, Zacharopoulou E, Hatzigeorgiou AG. DIANA-microT 2023: including predicted targets of virally encoded miRNAs. Nucleic Acids Research. 2023;51(W1):W148-W153. doi:10.1093/nar/gkad283
BibTeX
@article{Tastsoglou2023,
author = {Tastsoglou, Spyros and Alexiou, Athanasios and Karagkouni, Dimitra and Skoufos, Giorgos and Zacharopoulou, Elissavet and Hatzigeorgiou, Artemis G},
title = {DIANA-microT 2023: including predicted targets of virally encoded miRNAs},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {W1},
pages = {W148--W153},
doi = {10.1093/nar/gkad283}
}
EUVIMED